Alginates are a family of compounds that naturally occur in the cell wall and extracellular matrix of various species of brown seaweed, often comprising up to 40% of the plant’s biomass. Some species of bacteria have also been found to produce alginates, including the commonly infectious Pseudomonas aeruginosa. Alginates see extensive use in the cosmetics, food, and biomedical industries due to their physical properties and inherent biocompatibility.
The building blocks of alginates are guluronic and mannuronic acid, both monosaccharides closely related to glucose. These building blocks form long chains that, with the addition of water, generate an anionic polysaccharide scaffold within an aqueous matrix. Varying the proportions of guluronic and mannuronic acid generates alginate compounds with differing physical and chemical properties. With the addition of an ionic crosslinker such as calcium or barium, alginates form a resilient, flexible, solid/semisolid hydrogel. These hydrogels have been used extensively as a tissue interface in wound dressings and as a construct for encapsulating cells and other therapeutic compounds.
Fundamental Properties of Alginates
Various forms of alginate are approved by the FDA for use primarily as a thickening agent, and alginate is widely known to be biocompatible and biodegradable. While some evidence indicates that alginate hydrogels are non-antigenic, in vivo research has shown that animals and humans alike often mount a generalized foreign body immune response when significant amounts of alginate are introduced into the physiologic environment. With that said, various materials have been studied as modifying and augmenting agents to reduce the immunogenicity of alginate, with the varying promise.
Alginates are hydrophilic by nature, and crosslinked hydrogels contain a significant aqueous component. Due to the structural chemistry of alginate scaffolds, water and other small molecules diffuse freely throughout the hydrogel. Because of this, many therapeutic compounds diffuse out of alginate hydrogels at predictable and consistent rates, making them useful biomaterial carriers in drug delivery. Additionally, this characteristic allows alginate hydrogels to equilibrate with their environment to some extent, and consequently, alginate hydrogels can maintain a relatively physiologic internal environment in vivo conditions.
Alginates crosslink to form hydrogels under a generally flexible set of conditions, which allows for significant variability in the composition and characteristics of the resultant biomaterial. A wide variety of compounds can be combined with alginates without disrupting their ability to crosslink, including therapeutic molecules, extracellular matrix components, and other biomaterials like chitosan. Various crosslinking agents and methods can be employed to generate hydrogels with a range of stiffness and degradative characteristics. This compositional flexibility allows alginate to act as a versatile, modifiable, biologically compatible biomaterial construct.
Alginates in wound dressings
Alginate hydrogels have extensive utilization as wound interfaces in dressings intended to support healing following burns, pressure ulcers, venous ulcers, and other exudative cutaneous wounds. While the indications of alginate wound dressings are different in each of these contexts, a few underlying principles are generally relevant. Because alginates allow for the relatively free diffusion of water and solutes, alginate dressings are thought to generate a relatively physiologic environment at the wound interface that encourages healing. Additionally, some research postulates that calcium release from alginate hydrogels crosslinked with calcium stimulates coagulative pathways and which results in a healing response. While alginate dressings see extensive use in wound healing, few well-controlled studies definitively link their usage to improvements in outcomes. It remains undetermined whether this is due to a lack of published evidence or a lack of benefit achieved with these dressings.
Alginates in encapsulation
Modern drug delivery systems often utilize a “carrier” construct that protects and facilitates the delivery of the intended therapeutic compound(s). Because of their flexibility, modifiability, and well-studied biocompatibility, alginate-based hydrogels are often candidates for this application. Therapeutic agents ranging from insulin to doxorubicin to entire cells and tissues have been encapsulated within alginate, delivered into the physiologic environment, and studied in preclinical and clinical trials. Because alginates can crosslink with agents that are generally compatible with physiologic function (like calcium chloride solutions), cells and tissues can be added to alginates before crosslinking, making alginate hydrogels particularly advantageous biomaterial constructs for living cell and organoid encapsulation.
For patients with extensive cutaneous wounds, healthcare staff should consider alginate dressings as a means of maintaining a moist and semi-physiologic wound environment. However, it bears mentioning that systematic review has failed to substantiate the superiority of alginate dressings over other dressing types.
|||May TB,Shinabarger D,Maharaj R,Kato J,Chu L,DeVault JD,Roychoudhury S,Zielinski NA,Berry A,Rothmel RK, Alginate synthesis by Pseudomonas aeruginosa: a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clinical microbiology reviews. 1991 Apr [PubMed PMID: 1906371]|
|||Darrabie MD,Kendall WF,Opara EC, Effect of alginate composition and gelling cation on microbead swelling. Journal of microencapsulation. 2006 Sep [PubMed PMID: 17118877]|
|||Montanucci P,Terenzi S,Santi C,Pennoni I,Bini V,Pescara T,Basta G,Calafiore R, Insights in Behavior of Variably Formulated Alginate-Based Microcapsules for Cell Transplantation. BioMed research international. 2015 [PubMed PMID: 26078974]|
|||Ehrhart F,Mettler E,Böse T,Weber MM,Vásquez JA,Zimmermann H, Biocompatible coating of encapsulated cells using ionotropic gelation. PloS one. 2013 [PubMed PMID: 24039964]|
|||Tønnesen HH,Karlsen J, Alginate in drug delivery systems. Drug development and industrial pharmacy. 2002 Jul [PubMed PMID: 12149954]|
|||Jain D,Bar-Shalom D, Alginate drug delivery systems: application in context of pharmaceutical and biomedical research. Drug development and industrial pharmacy. 2014 Dec [PubMed PMID: 25109399]|
|||Lopes M,Abrahim B,Veiga F,Seiça R,Cabral LM,Arnaud P,Andrade JC,Ribeiro AJ, Preparation methods and applications behind alginate-based particles. Expert opinion on drug delivery. 2017 Jun [PubMed PMID: 27492462]|
|||Thomas S, Alginate dressings in surgery and wound management--Part 1. Journal of wound care. 2000 Feb [PubMed PMID: 11933281]|
|||Jana S,Sen KK,Gandhi A, Alginate Based Nanocarriers for Drug Delivery Applications. Current pharmaceutical design. 2016 [PubMed PMID: 27160752]|
|||Somo SI,Khanna O,Brey EM, Alginate Microbeads for Cell and Protein Delivery. Methods in molecular biology (Clifton, N.J.). 2017 [PubMed PMID: 27738939]|